How Dermatological Innovation Is Improving Patient Outcomes

Infectious disease threats are rising. Canada needs domestic capacity to detect, test, and develop solutions quickly. New infectious diseases continue to emerge, affecting human and animal health, food security, and economies. Many originate in animals, making a One Health approach that addresses the connection between human and animal health increasingly important. The challenge is not … Continued

Global drug policy changes are making it increasingly difficult for innovative new medicines to reach the Canadian market. There’s a quiet crisis unfolding behind closed doors. Canadians have the longest wait times in the G7 for public access to new and innovative medicines — the patented, breakthrough kind that treat cancer, autoimmune disorders, and rare … Continued